EP1962833A4 - Lichtaktivierbare antimikrobielle mittel - Google Patents

Lichtaktivierbare antimikrobielle mittel

Info

Publication number
EP1962833A4
EP1962833A4 EP06844370A EP06844370A EP1962833A4 EP 1962833 A4 EP1962833 A4 EP 1962833A4 EP 06844370 A EP06844370 A EP 06844370A EP 06844370 A EP06844370 A EP 06844370A EP 1962833 A4 EP1962833 A4 EP 1962833A4
Authority
EP
European Patent Office
Prior art keywords
antimicrobial agents
photoactivatable
photoactivatable antimicrobial
agents
antimicrobial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06844370A
Other languages
English (en)
French (fr)
Other versions
EP1962833A2 (de
Inventor
Tayyaba Hasan
Gerald J Nau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Original Assignee
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp filed Critical General Hospital Corp
Publication of EP1962833A2 publication Critical patent/EP1962833A2/de
Publication of EP1962833A4 publication Critical patent/EP1962833A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP06844370A 2005-11-15 2006-11-15 Lichtaktivierbare antimikrobielle mittel Withdrawn EP1962833A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73691705P 2005-11-15 2005-11-15
PCT/US2006/044369 WO2007059226A2 (en) 2005-11-15 2006-11-15 Photoactivatable antimicrobial agents

Publications (2)

Publication Number Publication Date
EP1962833A2 EP1962833A2 (de) 2008-09-03
EP1962833A4 true EP1962833A4 (de) 2012-02-01

Family

ID=38049279

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06844370A Withdrawn EP1962833A4 (de) 2005-11-15 2006-11-15 Lichtaktivierbare antimikrobielle mittel

Country Status (5)

Country Link
US (1) US20100016208A1 (de)
EP (1) EP1962833A4 (de)
AU (1) AU2006315443A1 (de)
CA (1) CA2633636A1 (de)
WO (1) WO2007059226A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9828622B2 (en) * 2008-05-05 2017-11-28 The General Hospital Corporation Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same
CA2733197A1 (en) * 2008-08-08 2010-02-11 Laamscience, Inc. Antimicrobial surfaces
JP5840126B2 (ja) * 2009-06-25 2016-01-06 スリーエム イノベイティブ プロパティズ カンパニー 光活性化抗微生物性物品及び使用方法
US20140141230A1 (en) * 2011-08-04 2014-05-22 Jason J. Locklin Permanent attachment of ammonium and guanidine-based antimicrobials to surfaces containing c-h functionality
US20160073634A1 (en) * 2012-06-22 2016-03-17 The General Hospital Corporation Beta-lactamase targeted photosensitizer for pesticide and pest detection
CN107759642B (zh) * 2017-11-13 2020-06-05 中南大学湘雅三医院 一种双糖基化苯并吩恶嗪类光敏剂及其制备方法和应用
WO2019109046A1 (en) 2017-11-30 2019-06-06 Arrakis Therapeutics, Inc. Nucleic acid-binding photoprobes and uses thereof
EP3726967A4 (de) * 2017-12-22 2021-03-17 Signify North America Corporation System und verfahren zum desinfizieren von eiern
CN110028557B (zh) * 2019-04-26 2022-07-05 常州大学 一种Ce6标记的双链抗菌肽及其合成方法和应用
CN112191022A (zh) * 2020-09-29 2021-01-08 南通大学 一种可太阳光驱动杀菌的熔喷过滤材料及制备方法
CN112191021A (zh) * 2020-09-29 2021-01-08 南通大学 一种喷涂式太阳光驱动杀菌熔喷材料及制备方法
CN112191025A (zh) * 2020-09-29 2021-01-08 南通大学 一种可太阳光驱动杀菌的个体防护过滤材料及制备方法
CN113425850B (zh) * 2021-06-04 2022-10-11 江南大学 光敏抗菌的改性卟啉金属有机骨架材料及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003697A2 (en) * 1995-07-19 1997-02-06 Consiglio Nazionale Delle Ricerche Fluorogenic substrates for diagnosis and photodynamic treatment of tumours
US20040115207A1 (en) * 1999-12-09 2004-06-17 Irwin Bernstein D Bioconjugates and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4740459A (en) * 1984-08-06 1988-04-26 Washington Research Foundation Fluorescence assay for microbial beta-lactamase
US5338843A (en) * 1992-01-30 1994-08-16 Becton, Dickinson And Company Fluorogenic and chromogenic β-lactamase substrates
US6462070B1 (en) * 1997-03-06 2002-10-08 The General Hospital Corporation Photosensitizer conjugates for pathogen targeting
US6727356B1 (en) * 1999-12-08 2004-04-27 Epoch Pharmaceuticals, Inc. Fluorescent quenching detection reagents and methods
US7741128B2 (en) * 2005-05-23 2010-06-22 University Of Hawaii Cooperative reporter systems, components, and methods for analyte detection

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997003697A2 (en) * 1995-07-19 1997-02-06 Consiglio Nazionale Delle Ricerche Fluorogenic substrates for diagnosis and photodynamic treatment of tumours
US20040115207A1 (en) * 1999-12-09 2004-06-17 Irwin Bernstein D Bioconjugates and uses thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BOUVIER J ET AL: "A fluorescent peptide substrate for the surface metalloprotease of Leishmania", EXPERIMENTAL PARASITOLOGY, NEW YORK, NY, US, vol. 76, no. 2, 1 March 1993 (1993-03-01), pages 146 - 155, XP002118379, ISSN: 0014-4894, DOI: 10.1006/EXPR.1993.1017 *
ROVALDI C R ET AL: "Photoactive porphyrin derivative with broad-spectrum activity against oral pathogens In vitro", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, vol. 44, no. 12, 1 December 2000 (2000-12-01), pages 3364 - 3367, XP003012287, ISSN: 0066-4804, DOI: 10.1128/AAC.44.12.3364-3367.2000 *
XING BENGANG ET AL: "Cell-permeable near-infrared fluorogenic substrates for imaging beta-lactamase activity", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 127, no. 12, 30 March 2005 (2005-03-30), pages 4158 - 4159, XP008142833, ISSN: 0002-7863 *
ZEINA B ET AL: "Killing of cutaneous microbial species by photodynamic therapy", BRITISH JOURNAL OF DERMATOLOGY, vol. 144, no. 2, February 2001 (2001-02-01), pages 274 - 278, XP002665949, ISSN: 0007-0963 *

Also Published As

Publication number Publication date
EP1962833A2 (de) 2008-09-03
WO2007059226A2 (en) 2007-05-24
US20100016208A1 (en) 2010-01-21
WO2007059226A3 (en) 2009-05-07
CA2633636A1 (en) 2007-05-24
AU2006315443A1 (en) 2007-05-24

Similar Documents

Publication Publication Date Title
LTPA2020524I1 (lt) Biocidiniai boronoftalido junginiai
DE602005002441D1 (de) Mikrobizide Zusammensetzung
DK2054030T3 (da) Antimikrobielle midler
CY2013047I2 (el) Ενωσεις διαρυλυδαντοϊνης
ATE408603T1 (de) Pyrazolylcarboxanilide
DK1965646T3 (da) Herbicid sammensætning
ATE477250T1 (de) Cyanoanthranilamidinsektizide
DK2554763T3 (da) Trådspole
DK1879877T3 (da) Antimikrobielle midler
ATE550315T1 (de) Pestizid-bi-phenyl-amidin-derivate
DE602006002695D1 (de) Mähwerksgehäuse
EP1797011A4 (de) Biozid
EP1893244A4 (de) Kontrastmittel
NL2000373A1 (nl) Antibacteriele middelen.
AT502689A3 (de) Erntemaschine
EP1962833A4 (de) Lichtaktivierbare antimikrobielle mittel
DK1793692T3 (da) Antimikrobiel sammensætning
ATE423466T1 (de) Herbizidzusammensetzung
DE502006001027D1 (de) Cyanuraten
DE602006020863D1 (de) Antimikrobielle zusammensetzung
DE602006018502D1 (de) Ng
DE502006004309D1 (de) Fungizide mischungen
DK1928245T3 (da) Herbicidsammensætning
AT502917A3 (de) Erntemaschine
DE602006019686D1 (de) Mähmaschine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080616

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

R17D Deferred search report published (corrected)

Effective date: 20090507

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/40 20060101ALI20090610BHEP

Ipc: A61K 38/00 20060101AFI20090610BHEP

REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1124756

Country of ref document: HK

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 45/06 20060101ALI20111221BHEP

Ipc: A61K 47/48 20060101ALI20111221BHEP

Ipc: A61K 31/39 20060101ALI20111221BHEP

Ipc: A61K 31/40 20060101ALI20111221BHEP

Ipc: A61K 38/00 20060101AFI20111221BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20120103

17Q First examination report despatched

Effective date: 20120116

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120727

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1124756

Country of ref document: HK